Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04086550 · ClinicalTrials.gov registry record · NA
Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
A NA study, sponsored by Polyganics.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT04086550: Completed NA study, sponsored by Polyganics.
NCT04086550 is a NA study that has completed, run by Polyganics. The registered enrollment target is 228 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04086550, a NA study, has completed, sponsored by Polyganics.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
The objective of the study is to clinically assess the safety and effectiveness of LIQOSEAL® as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure to show noninferiority compared to a control group.
Interventions
- DEVICE LIQOSEAL
- DEVICE DuraSeal, Adherus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2021-05-20 |
| Est. Completion | 2024-02-13 |
| Phase | NA |
What the finished NCT04086550 record still lists
NCT04086550 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which LIQOSEAL is the first listed.
NCT04086550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04086550 about?
NCT04086550 is a clinical study titled "Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery". The objective of the study is to clinically assess the safety and effectiveness of LIQOSEAL® as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure to show noninferiority compared to a control grou...
What is the current status of trial NCT04086550?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2021-05-20. Estimated completion is 2024-02-13.
What interventions are being tested in trial NCT04086550?
The interventions under investigation include: LIQOSEAL (DEVICE), DuraSeal, Adherus (DEVICE).
Who is sponsoring clinical trial NCT04086550?
This trial is sponsored by Polyganics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04086550's enrollment target sits among peer trials
228 468th of 2000 higher than 1,530 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI